Conditions: Pulmonary Arterial Hypertension
Keywords: Pulmonary arterial hypertension imatinib 6MWD
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 17
Healthy volunteers: no

Brief summary:
This study was an extension to study CQTI571A2102 and was to evaluate the long-term safety, tolerability and efficacy of QTI571 (imatinib) in severe pulmonary arterial hypertension patients.

Detailed description:

Arms:
arm 1: Participants received 200 mg or 400 mg every day (qd) based on their highest tolerated dose in CQTI571A2102 (NCT01392469).

Interventions: intervention 1: Imatinib
Intervention descriptions: intervention 1: 200 mg or 400 mg qd

Protocol document: